T-regulatory Cell Depletion With E7777 Combined With Pembrolizumab in Recurrent or Metastatic Solid Tumors
Clinical trial NCT05200559 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05200559
- Sponsor
- Alexander B Olawaiye, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-30
- Primary completion
- 2030-05-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.